Top Markets
Coin of the day
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company

Middle East Pharmaceutical Industries Company

4016
Pozycja w akcjach #12222
Middle East Pharmaceutical Industries Company (MEPIC), established in Riyadh,... Middle East Pharmaceutical Industries Company (MEPIC), established in Riyadh, Saudi Arabia, in 1998, is a global pharmaceutical entity. The company's core activities encompass the entire lifecycle of generic medicines and various pharmaceutical products, from research and development to manufacturing and sales, catering to both local and international markets. Its business operations are strategically divided into private sector, public sector, and export divisions. MEPIC offers an extensive array of products designed to address a wide range of medical conditions. This includes dermatological treatments, remedies for respiratory ailments, central nervous system disorders, digestive issues, and musculoskeletal complaints, alongside medications for the urinary and reproductive systems. Furthermore, the company provides disinfectants and a diverse portfolio of therapeutic agents covering areas such as sexual health, diabetes, cardiovascular diseases, anti-infectives, anti-parasitics, pain relief, antiseptics, and general men's and women's health. These pharmaceutical and health products are supplied in numerous formats, including creams, ointments, syrups, capsules, tablets, gels, lotions, sprays, topical solutions, and personal hygiene items like hand sanitizers, mouthwashes, and soaps. In addition to its proprietary product lines, MEPIC leverages its manufacturing capabilities to offer contract manufacturing services. The company also specializes in cosmetic products, general health aids, and nutritional supplements. Originally known as Middle East Chemical Products Factory Company, the organization officially rebranded to Middle East Pharmaceutical Industries Company in January 2006.
Cena akcji
$17.36
Ostatnia synchronizacja: 2026-08-30
Kapitalizacja rynkowa
$607.55M
Zmiana (1 dzień)
0.54%
Zmiana (1 rok)
-10.39%
Kraj
SA
Handel Middle East Pharmaceutical Industries Company (4016)

Kategoria

Cena 4016 z kapitalizacją rynkową B
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company
4016
$17.36
Kapitalizacja rynkowa Middle East Pharmaceutical Industries Company(4016)
Kapitalizacja rynkowa: $607.55M
Na dzień August 2026 spółka Middle East Pharmaceutical Industries Company ma kapitalizację rynkową wynoszącą $607.55M. Według naszych danych, czyni to Middle East Pharmaceutical Industries Company 12222nd najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Middle East Pharmaceutical Industries Company od 2024 do 2026
4016 w porównaniu do 5 najpopularniejszych stocks
Cena za 4016 Aktywa B Kapitalizacja rynkowa B Wyniki
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company
$150,396 $607.55M
$5.264T +866,305.79%
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company
$134,322 $607.55M
$4.701T +773,706.04%
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company
$119,348 $607.55M
$4.177T +687,442.16%
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company
$109,069 $607.55M
$3.817T +628,224.76%
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company
$81,895.34 $607.55M
$2.866T +471,684.43%